Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: James Baker who wrote (3018)	5/28/1998 11:33:00 PM
From: Marshall Teitelbaum	Respond to of 9523

Jim, Keep in mind that this is also another plug for ICOS by McCamant. One article today spoke of their drug being better because it is more specific toward the penis itself, thus bypassing the side effects of viagra. However, later in the same article it spoke of other possible indications for this product, including cardiac.....does this sound a bit paradoxical to anyone else?? If it's so specific to the penis phosphodiesterase system, then......???? FWIW, the new sample packs going into offices now are more typical of other drugs..... blister packs with 5 pills. This signals some increased marketing getting ready to begin, as if it's really necessary at this point. This will be a lot more patient-friendly than the bottle with 15 pills and handing out a few to each patient. Next step for Viagra per recent articles appears to be release in Brazil and Mexico...any other places expected by early summer? Regards, Marshall